Aptamer Sciences Inc (KOSDAQ:291650)
South Korea · Delayed Price · Currency is KRW 950.00
+98.00 (11.50%)
At close: Jul 21, 2026
Aptamer Sciences Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue Revenue Growth | 1,083 | 1,083 | 243.19 | 358.25 | 269.28 | 228.51 |
Revenue Growth | 281.58% | 345.26% | -32.12% | 33.04% | 17.84% | -43.94% |
Gross Profit Gross Profit Growth | 772 | 772 | 191.08 | 286.58 | 156.41 | 157.44 |
Operating Income Operating Income Growth | -7,052 | -7,052 | -12,207 | -8,320 | -4,067 | -3,923 |
Net Income Net Income Growth | -8,702 | -8,702 | -13,602 | -7,116 | -3,831 | -3,843 |
Earnings Per Share EPS Growth | -494.00 | -494.00 | -801.00 | -419.38 | -226.00 | -511.00 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Analysis Service Analysis Service Growth | 876.25 | - | - | - | - |
Synthetic Service Synthetic Service Growth | 198.97 | 215.14 | 319.33 | 183.32 | 152.56 |
Excavation Service Excavation Service Growth | 6.86 | 28.05 | 36.07 | 45.93 | 57.75 |
Lung Cancer Diagnosis Kit Lung Cancer Diagnosis Kit Growth | 0.74 | - | 2.86 | - | 15.4 |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Investments Cash & Investments Growth | 17,497 | 17,497 | 23,785 | 35,402 | 24,209 | 34,863 |
Total Debt Total Debt Growth | 1,984 | 1,984 | 8,281 | 6,936 | 106.87 | 115.74 |
Net Cash (Debt) Net Cash Growth | 15,513 | 15,513 | 15,504 | 28,466 | 24,103 | 34,747 |
Net Cash Growth | -18.63% | 0.06% | -45.53% | 18.10% | -30.64% | 377.30% |
Net Cash Per Share Net Cash Per Share Growth | 880.62 | 880.62 | 913.04 | 1677.71 | 1421.85 | 4619.83 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | -5,897 | -5,897 | -11,236 | -5,776 | -3,474 | -3,409 |
Capital Expenditures CapEx Growth | -1,080 | -1,080 | -297.14 | -308.88 | -7,081 | -349.37 |
Free Cash Flow Free Cash Flow Growth | -6,977 | -6,977 | -11,534 | -6,085 | -10,555 | -3,758 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Gross Margin | 71.30% | 71.30% | 78.57% | 79.99% | 58.09% | 68.90% |
Operating Margin | -651.23% | -651.23% | -5019.47% | -2322.35% | -1510.39% | -1716.79% |
Pretax Margin | -803.68% | -803.68% | -5593.04% | -2317.16% | -1422.73% | -1681.97% |
Profit Margin | -803.68% | -803.68% | -5593.04% | -1986.19% | -1422.73% | -1681.97% |
FCF Margin | -644.35% | -644.35% | -4742.72% | -1698.50% | -3919.93% | -1644.68% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PS Ratio | - | 29.58 | 251.72 | 207.36 | 536.06 | 1000.35 |